HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aditya Lele Selected Research

fenofibric acid

6/2014Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
6/2014Baseline very low-density lipoprotein cholesterol is associated with the magnitude of triglyceride lowering on statins, fenofibric acid, or their combination in patients with mixed dyslipidemia.
8/2013A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
11/2012Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
3/2011Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
2/2011Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
4/2009Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aditya Lele Research Topics

Disease

7Dyslipidemias (Dyslipidemia)
06/2014 - 04/2009
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Coronary Disease (Coronary Heart Disease)
06/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2014
1Chronic Renal Insufficiency
08/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2012
1Hypertriglyceridemia
02/2011

Drug/Important Bio-Agent (IBA)

7fenofibric acidFDA Link
06/2014 - 04/2009
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014 - 04/2009
4Triglycerides (Triacylglycerol)IBA
06/2014 - 02/2011
4LipidsIBA
08/2013 - 04/2009
3LDL CholesterolIBA
06/2014 - 02/2011
3Rosuvastatin Calcium (Crestor)FDA Link
08/2013 - 02/2011
2HDL CholesterolIBA
06/2014 - 03/2011
2Atorvastatin (Lipitor)FDA Link
06/2014 - 02/2011
2oxidized low density lipoproteinIBA
11/2012 - 02/2011
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2016
1AndrogensIBA
01/2016
1Choline (Choline Chloride)IBA
06/2014
1Fibric Acids (Fibrates)IBA
06/2014
1Fenofibrate (CiL)FDA LinkGeneric
06/2014
1VLDL CholesterolIBA
06/2014
1Lipoproteins (Lipoprotein)IBA
11/2012
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2011
1HDL LipoproteinsIBA
03/2011
1Simvastatin (Zocor)FDA LinkGeneric
02/2011

Therapy/Procedure

6Therapeutics
01/2016 - 04/2009